CIK 0001574232 · Non-accelerated filer
Addex Therapeutics Ltd.
Sign in to watch- Ticker
- ADXN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 01141228841555
- Business address
- CHEMIN DES MINES 9, GENEVA, Switzerland, CH-1202
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | Dyer Timothy Mark CHIEF EXECUTIVE OFFICER | Returned to the company | −16,413,787 | 435,192 | ||
| 2026-09-02 | Dyer Timothy Mark CHIEF EXECUTIVE OFFICER | Grant or award | +16,413,787 | 16,848,979 | ||
| 2026-09-02 | Dyer Timothy Mark CHIEF EXECUTIVE OFFICER | Returned to the company · Stock-option (Right to Buy) | −3,369,796 | 0 | ||
| 2026-09-02 | Dyer Timothy Mark CHIEF EXECUTIVE OFFICER | Grant or award · Stock-option (Right to Buy) | +3,369,796 | 3,369,796 |
Page 3 of 3 · 44 trades